ProCE Banner Activity

Germline BRCA Testing and Targeting in HER2-Negative Early-Stage Breast Cancer

Slideset

Downloadable slideset with the latest expert guidance on germline BRCA testing and targeting in patients with HER2-negative early-stage breast cancer.

Released: May 07, 2024

Expiration: May 06, 2025

Share

Provided by

Provided by Clinical Care Options, LLC in partnership with Breastcancer.org

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Merck Sharp & Dohme, LLC, and Novartis Pharmaceuticals Corporation.

AstraZeneca

Merck Sharp & Dohme, LLC

Novartis Pharmaceuticals Corporation

Partners

Breastcancer.org

ProCE Banner